HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$4.70
Day range
$4.66 - $5.06
Year range
$2.31 - $7.15
Market cap
25.03M USD
Avg Volume
112.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 216.19K | — |
Operating expense | 2.81M | 9.71% |
Net income | -2.28M | -2.35% |
Net profit margin | -1.06K | — |
Earnings per share | — | — |
EBITDA | -2.59M | -1.06% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 22.04M | -32.26% |
Total assets | 23.00M | -38.73% |
Total liabilities | 2.63M | 37.93% |
Total equity | 20.37M | — |
Shares outstanding | 5.32M | — |
Price to book | 1.23 | — |
Return on assets | -27.15% | — |
Return on capital | -29.86% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.28M | -2.35% |
Cash from operations | -2.02M | -9.97% |
Cash from investing | 2.73M | 5.02% |
Cash from financing | -5.30K | 10.19% |
Net change in cash | 699.05K | -6.98% |
Free cash flow | -1.42M | -46.09% |
About
Founded
1997
Headquarters
Website
Employees
17